Parkson Retail Asia, on Dec 4, 2023, sought to extend its cure period to Dec 2 this year, so that the company can meet SGX’s listing requirements under Rule 1314 of the listing manual. The application came after the company’s average daily market capitalisation exceeded the $40 million required over the last six months. The company also achieved a healthy cash flow from its operating activities for the FY2022 ended Dec 31, 2022 among other factors.
Parkson Retail Asia, the 67.96%-owned subsidiary of Bursa-listed Parkson Holdings, has exited from the Singapore Exchange (SGX:S68
) ’s (SGX) watch-list on Oct 4.
An approval in-principle was given to the company by the Singapore Exchange Securities Trading Limited (SGX-ST) via a letter dated Oct 2.
